TELA Bio (TELA) Return on Capital Employed Growth (3y) (2022 - 2026)
TELA Bio (TELA) Return on Capital Employed Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -236.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 281.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 446.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -433.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1,627.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -62.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 370.00 |
| 10 | TELA Bio | 36.34 Mn | 5.92 Mn | 13.94 Mn | -919.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -919.00 |
| Mar 31, 2026 | 2,415.00 |
| Dec 31, 2025 | 57.00 |
| Sep 30, 2025 | -42.00 |
| Jun 30, 2025 | 1,450.00 |
| Mar 31, 2025 | 781.00 |
| Dec 31, 2024 | -950.00 |
| Sep 30, 2024 | -4,960.00 |
| Jun 30, 2024 | -3,514.00 |
| Mar 31, 2024 | -2,906.00 |
| Dec 31, 2023 | -3,654.00 |
| Sep 30, 2023 | -2,743.00 |
| Jun 30, 2023 | -3,518.00 |
| Mar 31, 2023 | -4,800.00 |
| Dec 31, 2022 | -1,421.00 |
| Sep 30, 2022 | 22,890.00 |